Banasik et al., "Specific inhibitors of poly(ADP-Ribose) synthetase and mono(ADP-ribosyl)transferase"J. Biol. Chem. (1992) 267:1569-1575. |
Beal, M.F. in Mitochondrial Dysfunction and Oxidative Damage in Neurodegenerative Diseases, R. G. Landes Publications Austin, TX, (1995) pp. 53-61 and 73-99. |
Bishop et al., "Synthesis and in vitro Evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D.sub.2 receptors" J. Med. Chem.(1991) 34:1612-1624. |
Burns, R.S., et al. "A Primate Model of Parkinsonism..."Proc. Natl. Acad. Sci USA(1983) 80:4546-4550. |
Calne, D.B., "Treatment of Parkinson's Disease " NEJM (Sept. 30, 1993) 329:1021-1027. |
El Tayar, et al., "Interaction of neuroleptic drugs with rat striatal D-1 and D-2 dopamine receptors: a quantitative structure-affinity relationship study " Eur. J. Med. Chem. (1988) 23:173-182. |
Gerlach, M. et al., "MPTP Mechanisms of Neurotoxicity and the Implications for Parkinson's Disease" European Journal of Pharmacology (1991) 208:273-286. |
Heikkila, R.E., et al., "Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice" Science (Jun. 29, 1984) 224:1451-1453. |
Hogberg et al., "Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a patent class of substituted (R)-N-[benzyl-2-pyrrolidinyl)methyl]benzamides. Relations toother side chain congeners"J. Med. Chem. Bull. (1976) 24, 3:431-436. |
Katopodis et al., "Novel substrates and inhibitors of peptidylglycine .alpha.-amidating monooxygenase " Biochemistry (1990) 29:4541-4548. |
Langston, J.W., et al. "Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis " Science (Feb. 25, 1983) 219, 979-980. |
Mizuno, Y., Mori, H., Kondo, T. "Potential of Neuroprotective Therapy in Parkinson's Disease "CNS Drugs (1994) 1:45-46. |
Monkovicet al., "Potential non-dopaminergic gastrointestinal prokinetic agents in the series of substituted benzamides " Eur. J. Med. Chem. (1989) 24;233-240. |
Rainnie et al., "Adenosine inhibition of mesopontine cholinergic neurons:implications for EEG arousal " Science (1994) 263:689-690. |
Singer, T.P. et al., "Biochemical Events in the Development of Parkinsonism..." J. neurochem. (1987) 1-8. |
Marsden, C.D., in "Review Article-Parkinson's Disease" Lancet (Apr. 21, 1990) 948-952. |
Abstract of Japanese Patent 58 67,657, Apr. 1983; Chem Abstract, vol. 99, No. 53390c, 1983. |